Kinesin Family Member 2A (Kif2A) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Kinesin Family Member 2A (Kif2A) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KIF2A (Kinesin Family Member 2A) encodes a motor protein of the kinesin-13 family with unique functions in microtubule depolymerization rather than intracellular transport. Unlike conventional kinesins that walk along microtubules, KIF2A promotes microtubule disassembly, critical for cellular processes including mitosis, neuronal development, and synaptic plasticity.
| Attribute | Value |
|---|---|
| Gene Symbol | KIF2A |
| Protein Name | Kinesin Family Member 2A / Kinesin-13A |
| Molecular Weight | ~80 kDa |
| UniProt ID | O00139 |
| PDB Structure | 3kin, 4omv |
| Subcellular Localization | Cytoplasm, centrosome, neuronal processes |
KIF2A contains an N-terminal motor domain with ATP-dependent microtubule-binding activity, connected to a C-terminal tail that regulates its localization and function. The motor domain adopts a typical kinesin fold with nucleotide-binding motifs (P-loop, switch I, switch II) that couple ATP hydrolysis to conformational changes 1.
Unlike processive kinesins (like KIF5), KIF2A exhibits ATP-dependent microtubule depolymerization activity. It can bind to microtubule ends and destabilize protofilaments, promoting catastrophe (transition from growth to shrinkage) 2.
KIF2A plays critical roles in neuronal development:
In mature neurons, KIF2A regulates synaptic structure and function by controlling microtubule dynamics at synapses. It influences presynaptic vesicle availability and postsynaptic receptor trafficking.
KIF2A localizes to centrosomes and regulates mitotic spindle dynamics, ensuring proper chromosome segregation during mitosis.
KIF2A has been implicated in AD pathophysiology. Studies show altered KIF2A expression in AD brain tissue, particularly in regions vulnerable to neurodegeneration (hippocampus, cortex). KIF2A may influence amyloid precursor protein (APP) trafficking and processing 4. Its role in microtubule dynamics affects tau phosphorylation and aggregation.
De novo KIF2A mutations cause cortical malformation and intractable epilepsy. The mutations impair neuronal migration during development, leading to lissencephaly and severe early-onset seizures 5.
KIF2A is overexpressed in various cancers and promotes cell proliferation and metastasis. It represents a potential therapeutic target.
Kinesin Family Member 2A (Kif2A) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Kinesin Family Member 2A (Kif2A) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.